课题基金 / 基金详情

MOLECULAR APPROACH TO GONADOTROPIN RECEPTOR REGULATION

MOLECULAR APPROACH TO GONADOTROPIN RECEPTOR REGULATION
促性腺激素受体调节的分子方法
批准号:
3320173
负责人:
JAY wimalasena WIMALASENA
金额:
$10.04万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1989-11-30

项目摘要

项目成果

JAY wimalasena WIMALASENA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have successfully developed procedures to solubilize LH/hCG receptors (LHR) from porcine and rat ovaries in high yield. Porcine and rat LHR have been purified to apparent homogeneity by a two-step hCG-Sepharose affinity chromatographic procedure. The predominant subunit of LHR so purified has a molecular weight of 70,000 - 80,000 Daltons under denaturing reducing conditions. During the proposed grant period, the physico-chemical and biological properties of purified rat and porcine LHR will be compared. Antibodies to porcine LHR will be developed in rabbits, and rat LHR will be injected into mice with the goal of producing a monoclonal antibody to rat LHR. Antibodies will be characterized by immunochemical techniques and their biological properties will be tested using isolated receptors, membranes, cultured cells and the whole animal. The molecular basis of receptor regulation by hormones will be analyzed through direct measurements of rates of synthesis and degradation of LHR by specific immunoprecipitation methodology. Receptor antibodies will provide a superb analytical tool for investigation of the molecular biology of LHR synthesis, processing and turnover. LHR antibodies will not only be critical tools for investigation of ovarian physiology at the molecular level, but also may have significant practical application in immunocontraception and in understanding infertility of ovarian origin and in the development of monoclonal LHR antibody-drug conjugates which may be useful in therapy of ovarian cancer.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1530-0277.1990.tb01192.x
发表时间: 1990-08
期刊: Alcoholism, clinical and experimental research
影响因子: --
作者: [S. Saxena;D. Meehan;P. Coney;J. Wimalasena]
通讯作者: S. Saxena;D. Meehan;P. Coney;J. Wimalasena
Biological actions of monoclonal luteinizing hormone/human chorionic gonadotropin receptor antibodies.
单克隆黄体生成激素/人绒毛膜促性腺激素受体抗体的生物学作用。
DOI: 10.1095/biolreprod46.2.265
发表时间: 1992
期刊: Biology of reproduction
影响因子: 3.6
作者: [Indrapichate,K, Meehan,D, Lane,TA, Chu,SY, Rao,CV, Johnson,D, Chen,TT, Wimalasena,J]
通讯作者: Wimalasena,J
Purification and characterization of the human ovarian LH/hCG receptor and comparison of the properties of mammalian LH/hCG receptors.
人卵巢 LH/hCG 受体的纯化和表征以及哺乳动物 LH/hCG 受体特性的比较。
DOI: 10.1016/0006-2952(90)90240-l
发表时间: 1990
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Alpaugh,K, Indrapichate,K, Abel,JA, Rimerman,R, Wimalasena,J]
通讯作者: Wimalasena,J
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
  • 批准号:
    6342200
  • 项目类别:
  • 资助金额:
    $19.77万
  • 财政年份:
    2000
  • 负责人:
    JAY wimalasena WIMALASENA
  • 依托单位:
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
  • 批准号:
    6032882
  • 项目类别:
  • 资助金额:
    $23.73万
  • 财政年份:
    2000
  • 负责人:
    JAY wimalasena WIMALASENA
  • 依托单位:
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
  • 批准号:
    6626727
  • 项目类别:
  • 资助金额:
    $20.91万
  • 财政年份:
    2000
  • 负责人:
    JAY wimalasena WIMALASENA
  • 依托单位:
APOPTOSIS & CELL CYCLE IN BREAST & OVARIAN CANCER CELLS
  • 批准号:
    6489338
  • 项目类别:
  • 资助金额:
    $20.33万
  • 财政年份:
    2000
  • 负责人:
    JAY wimalasena WIMALASENA
  • 依托单位:
海外基金